Literature DB >> 21074634

The graphical representation of ADME-related molecule properties for medicinal chemists.

Timothy J Ritchie1, Peter Ertl, Richard Lewis.   

Abstract

The importance of striving for and maintaining drug-like physicochemical properties during the hit and lead optimization process is now well documented, and many published studies have suggested optimal ranges and/or limits for key molecule descriptors such as size, lipophilicity, H-bonding characteristics, rotatable bond and aromatic ring counts, particularly with regard to the design of orally administered drugs. The aim of this article is to review various approaches that have been used to represent molecule properties graphically in the context of oral 'drug likeness', with the goal of improving the decision making of medicinal chemists during the drug discovery process.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21074634     DOI: 10.1016/j.drudis.2010.11.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  23 in total

Review 1.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

2.  Inflation of correlation in the pursuit of drug-likeness.

Authors:  Peter W Kenny; Carlos A Montanari
Journal:  J Comput Aided Mol Des       Date:  2013-01-10       Impact factor: 3.686

3.  Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Anushka C Galasiti Kankanamalage; Roxanne Adeline Z Uy; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2013-08-22       Impact factor: 2.823

4.  Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.

Authors:  Chirag N Patel; John J Georrge; Krunal M Modi; Moksha B Narechania; Daxesh P Patel; Frank J Gonzalez; Himanshu A Pandya
Journal:  J Biomol Struct Dyn       Date:  2017-12-27

5.  Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease.

Authors:  Kok-Chuan Tiew; Guijia He; Sridhar Aravapalli; Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2011-07-14       Impact factor: 2.823

6.  Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles.

Authors:  Sivakoteswara Rao Mandadapu; Pathum M Weerawarna; Mallikarjuna Reddy Gunnam; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-05-26       Impact factor: 2.823

7.  Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies.

Authors:  Anjila Kumari; Tara Jaiswal; Vinay Kumar; Neha Hura; Gulshan Kumar; Neerupudi Kishore Babu; Ayan Acharya; Pradyot K Roy; Sankar K Guchhait; Sushma Singh
Journal:  RSC Med Chem       Date:  2022-01-06

8.  Integrating In Silico and In Vitro Approaches to Screen the Antidiabetic Properties from Tabernaemontana divaricata (Jasmine) Flowers.

Authors:  Saima Muzammil; Rahat Andleeb; Sumreen Hayat; Muhammad Umar Ijaz; Asma Ashraf; Nimrah Zafar; Shabana Naz; Mubashera Shaheen
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

9.  Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Kok-Chuan Tiew; Roxanne Adeline Z Uy; Allan M Prior; Kevin R Alliston; Duy H Hua; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-11-21       Impact factor: 2.823

10.  Structural features determining the intestinal epithelial permeability and efflux of novel HIV-1 protease inhibitors.

Authors:  Lucia Lazorova; Ina Hubatsch; Jenny K Ekegren; Johan Gising; Daisuke Nakai; Noha M Zaki; Christel A S Bergström; Ulf Norinder; Mats Larhed; Per Artursson
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.